JXHL0600105 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2006-04-13 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2007-07-11 | view |
JXHL0700225 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | Import Drug Application | 2007-08-22 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2008-09-03 | view |
JXHL0700224 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | Import Drug Application | 2007-08-22 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2008-09-03 | view |
JXHS0900071 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Import Drug Application | 2009-12-10 | Bristol-Myers Squibb Pharma EEIG | Bristol-Myers Squibb Pharma Eeig | Certificate Issued | 2011-09-22 | view |
JXHS0900069 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Import Drug Application | 2009-12-10 | Bristol-Myers Squibb Pharma EEIG | Bristol-Myers Squibb Pharma Eeig | Certificate Issued | 2011-09-22 | view |
JXHS0900070 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Import Drug Application | 2009-12-10 | Bristol-Myers Squibb Pharma EEIG | Bristol-Myers Squibb Pharma Eeig | Certificate Issued | 2011-09-22 | view |
JXHS0900068 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Import Drug Application | 2009-12-10 | Bristol-Myers Squibb Pharma EEIG | Bristol-Myers Squibb Pharma Eeig | Certificate Issued | 2011-09-22 | view |
CXHL1000220 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-06-03 | 江苏正大天晴药业股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2012-03-30 | view |
CXHL1000219 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-06-03 | 江苏正大天晴药业股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2012-03-30 | view |
CXHL1000218 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-06-03 | 江苏正大天晴药业股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2012-03-30 | view |
CXHL1000334 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-08-09 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2012-11-06 | view |
CXHL1000333 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-08-09 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2012-11-06 | view |
CXHL1000332 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-08-09 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2012-11-06 | view |
CXHL1000331 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2010-08-09 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2012-11-06 | view |
CXHL1100174 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2011-05-09 | 南京圣和药业有限公司 | Nanjing Sanhome Pharmaceutical CoLtd | Certificate Issued | 2015-03-02 | view |
CXHL1100176 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2011-05-09 | 南京圣和药业有限公司 | Nanjing Sanhome Pharmaceutical CoLtd | Certificate Issued | 2015-03-02 | view |
CXHL1100175 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2011-05-09 | 南京圣和药业有限公司 | Nanjing Sanhome Pharmaceutical CoLtd | Certificate Issued | 2015-03-02 | view |
CXHL1100173 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(3.1) | New Drug Application | 2011-05-09 | 南京圣和药业有限公司 | Nanjing Sanhome Pharmaceutical CoLtd | Certificate Issued | 2015-03-02 | view |
JYHB1200309 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2012-04-05 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2013-01-15 | view |
JYHB1200308 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2012-04-05 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2013-01-15 | view |